Thermal-based treatment options for localized prostate cancer

Current Treatment Options in Oncology

Volumn 6, Issue 5, 2005, Pages 379-387

  Koch, Michael O ^a   Gardner, Thomas A ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGON; PROSTATE SPECIFIC ANTIGEN;

CANCER GRADING; CANCER HORMONE THERAPY; CANCER RISK; CANCER SURVIVAL; CRYOSURGERY; CRYOTHERAPY; ECCHYMOSIS; EDEMA; FREEZE THAWING; GENERAL ANESTHESIA; GLEASON SCORE; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; ILEUS; IMPOTENCE; INCONTINENCE; INTERMETHOD COMPARISON; MALE; MORBIDITY; PATHOPHYSIOLOGY; PENIS DISEASE; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RECTUM FISTULA; REVIEW; RISK ASSESSMENT; SURGICAL APPROACH; SURVIVAL RATE; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT OUTCOME; URETER FISTULA; URINE RETENTION;

EID: 28044432779     PISSN: 15272729     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11864-005-0041-y     Document Type: Review

References (32)

1. Begg CB, Riedel ER, Bach PB, et al.: Variations in morbidity after radical prostatectomy. N Engl J Med 2002, 346:1138-1144.
2. Benoit RM, Naslund MJ, Cohen JK: Complications after prostate brachytherapy in the Medicare population. Urology 2000, 55:91-96.
3. Bonney WW, Fallon B, Gerber WL, et al.: Cryosurgery in prostatic cancer: survival. Urology 1982, 19:37-42.
4. Onik GM, Cohen JK, Reyes GD, et al.: Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate. Cancer 1993, 72:1291-1299.
5. Long JP, Bahn D, Lee F, et al.: Five-year retrospective multi-institutional pooled analysis of cancer related outcomes after cryosurgical ablation of the prostate. Urology 2001, 57:518-523.
6. Donnelly BJ, Saliken JC, Ernst DS, et al.: Prospective trial of cryosurgical ablation of the prostate; 5 year results. Urology 2002, 60:645-649.
7. Aus G, Pilebad E, Hugosson J: Cryosurgical ablation of the prostate: 5 year follow-up of a prospective study. Eur Urol 2002, 42:133-138.
8. Han KR, Belldegrun AS: Third-generation cryosurgery for primary and recurrent prostate cancer. BJU Int 2004, 93:14-18.
9. Prepelica KL, Okeke Z, Murphy A, et al.: Cryosurgical ablation of the prostate: high risk patient outcomes. Cancer 2005, 103:1625-1630.
10. Ghafar MA, Johnson CW, De La Taille: Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience. J Urol 2001, 166:1333-1338.
11. Fry WJ, Mosberg WH, Barnard JW, et al.: Production of focal destructive lesions in the central nervous system with ultrasound. J Neurosurg 1954, 11:471-478.
12. Fry FJ, Johnson LK: Tumor irradiation with intense ultrasound. Ultrasound Med Biol 1978, 4:337-341.
13. Vaezy S, Martin R, Leilman G, et al.: Control of splenic bleeding by using high intensity ultrasound. J Trauma 1999, 47:3.
14. Vaezy S, Martin R, Schmiedl U, et al.: Liver hemostasis using high-intensity focused ultrasound. Ultrasound Med Biol 1997, 23:1413-1420.
15. Wu F, Chen WZ, Bai J, et al.: Pathologic changes in malignant carcinoma treated with high intensity focused ultrasound. Ultrasound Med Biol 2001, 27:1099-1106.
16. Gelet A, Chapelon JY, Margonari J, et al.: Prostatic tissue destruction by high-intensity focused ultrasound: experimentation on canine prostate. J Endourol 1993, 7:3.
17. Bihrle R, Foster RS, Sanghvi NT, et al.: High-intenstiy focused ultrasound in the treatment of prostatic tissue. Urology 1994, 43 (Suppl 2):
18. Kincaide LF, Sanghvi NT, Cummings O, et al.: Noninvasive Ultrasonic Subtotal Ablation of the Prostate in Dogs. Am J Vet Res 1996, 57:8.
19. Madersbacher S, Kratzik C, Susani M, et al.: Tissue ablation benign prostatic hyperplasia using high intensity focused ultrasound. J Urol 1994, 152:1956-1961.
20. Bihrle R, Foster R, Sanghvi NT, et al.: High Intensity focused ultrasound for the treatment of benign prostatic hyperplasia: early United States experience. J Urol 1994, 151:1271-1275.
21. Madersbacher S, Schatzl G, Djavan B, et al.: Long-term outcome of transrectal high-intensity focused ultrasound therapy for benign prostatic hyperplasia. Eur Urology 2000, 37:687-694.
22. Nakamura K, Baba S, Saito S, et al.: High-intensity focused ultrasound energy for benign prostatic hyperplasia: clinical response at 6 months to treatment using Sonoblate 200. J Endourol 1997, 11:197-201.
23. Madersbacher S, Pedevilla M, Vingers L, et al.: Effect of High-Intensity Focused ULtrasound on HUman Prostate Cancer in Vivo. Cancer Research 55, 1995.
24. Beerlage HP, van Leenders GJ, Oosterhof GO, et al.: High-intensity focused ultrasound followed after one to two weeks by radical retropubic prostatectomy: Results of a prospective study. Prostate 1999, 39:1.
25. Gelet A, Chapelon JY, Margonari J, et al.: Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience. Eur Urol 1996, 29:174.
26. Kiel HJ, Weiland WF, Rossler W: Local control of prostate cancer by transrectal HIFU therapy. Arch Ital Urol Androl 2000, 72:313-319.
27. Gelet A, Chapelon JY, Bouvier R, et al.: Transrectal high-intensity focused ultrasound: minimally invasive therapy of localized prostate cancer. J Endourology 2000, 14:519-528.
28. Chaussy C, Thuroff S: High-intensity focused ultrasound in prostate cancer: results after 3 years. Mol Urol 2000, 4:179-182.
29. Thuroff S, Chaussy C: High-intensity focused ultrasound: complications and adverse events. Mol Urol 2000, 4:183-187.
30. Thuroff S, Chaussy CC, Vallancien G, et al.: High-intensity focused ultrasound and localized prostate cancer: Efficacy results from the European multicentric study. J Endourol 2003, 17:673-677.
31. Uchida T, Sanghvi NT, Gardner TA, et al.: Transrectal high-intensity focused ultrasound for treatment of patients with stage T1b-T2bN0M0 localized prostate cancer. Urology 2002, 59:394-398.
32. Uchida T: High intensity focused ultrasound for localized prostate cancer. Nippon Rinsho 2005, 63:345-349.